Literature DB >> 19546810

Technical standards and guidelines for myotonic dystrophy type 1 testing.

Thomas W Prior1.   

Abstract

Myotonic dystrophy type 1 is an autosomal dominant multisystem condition. Myotonic dystrophy type 1 is the result of an unstable CTG expansion in the 3'-untranslated region of the myotonic dystrophy protein kinase gene. The age of onset and the severity of the phenotype are roughly correlated with the size of the CTG expansion. The combination of Southern transfer and polymerase chain reaction provides an accurate means of identifying patients affected by myotonic dystrophy type 1. This document follows the outline format of the general Standards and Guidelines for Clinical Genetics Laboratories. It is designed to be a checklist for genetic testing professionals who are already familiar with the disease and the methods of analysis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19546810     DOI: 10.1097/GIM.0b013e3181abce0f

Source DB:  PubMed          Journal:  Genet Med        ISSN: 1098-3600            Impact factor:   8.822


  10 in total

Review 1.  Myotonic dystrophy: disease repeat range, penetrance, age of onset, and relationship between repeat size and phenotypes.

Authors:  Kevin Yum; Eric T Wang; Auinash Kalsotra
Journal:  Curr Opin Genet Dev       Date:  2017-02-14       Impact factor: 5.578

2.  Development of a genomic DNA reference material panel for myotonic dystrophy type 1 (DM1) genetic testing.

Authors:  Lisa Kalman; Jack Tarleton; Monica Hitch; Madhuri Hegde; Nick Hjelm; Elizabeth Berry-Kravis; Lili Zhou; James E Hilbert; Elizabeth A Luebbe; Richard T Moxley; Lorraine Toji
Journal:  J Mol Diagn       Date:  2013-05-13       Impact factor: 5.568

3.  Molecular, clinical, and muscle studies in myotonic dystrophy type 1 (DM1) associated with novel variant CCG expansions.

Authors:  Massimo Santoro; Marcella Masciullo; Roberta Pietrobono; Giulia Conte; Anna Modoni; Maria Laura E Bianchi; Valentina Rizzo; Maria Grazia Pomponi; Giorgio Tasca; Giovanni Neri; Gabriella Silvestri
Journal:  J Neurol       Date:  2012-12-23       Impact factor: 4.849

4.  Modifying the Medical Research Council grading system through Rasch analyses.

Authors:  Els Karla Vanhoutte; Catharina Gerritdina Faber; Sonja Ingrid van Nes; Bart Casper Jacobs; Pieter Antoon van Doorn; Rinske van Koningsveld; David Reid Cornblath; Anneke Jelly van der Kooi; Elisabeth Aviva Cats; Leonard Hendrik van den Berg; Nicolette Claudia Notermans; Willem Lodewijk van der Pol; Mieke Catharina Elisabeth Hermans; Nadine Anna Maria Elisabeth van der Beek; Kenneth Craig Gorson; Marijke Eurelings; Jeroen Engelsman; Hendrik Boot; Ronaldus Jacobus Meijer; Giuseppe Lauria; Alan Tennant; Ingemar Sergio José Merkies
Journal:  Brain       Date:  2011-12-20       Impact factor: 13.501

5.  Detection of large expansions in myotonic dystrophy type 1 using triplet primed PCR.

Authors:  Susmita Singh; Amy Zhang; Stephen Dlouhy; Shaochun Bai
Journal:  Front Genet       Date:  2014-04-24       Impact factor: 4.599

6.  Clinical characteristics of pregnancies complicated by congenital myotonic dystrophy.

Authors:  Cheonga Yee; Suk-Joo Choi; Soo-Young Oh; Chang-Seok Ki; Cheong-Rae Roh; Jong-Hwa Kim
Journal:  Obstet Gynecol Sci       Date:  2017-07-14

7.  The Need for Establishing a Universal CTG Sizing Method in Myotonic Dystrophy Type 1.

Authors:  Alfonsina Ballester-Lopez; Ian Linares-Pardo; Emma Koehorst; Judit Núñez-Manchón; Guillem Pintos-Morell; Jaume Coll-Cantí; Miriam Almendrote; Giuseppe Lucente; Andrea Arbex; Jonathan J Magaña; Nadia M Murillo-Melo; Alejandro Lucia; Darren G Monckton; Sarah A Cumming; Alba Ramos-Fransi; Alicia Martínez-Piñeiro; Gisela Nogales-Gadea
Journal:  Genes (Basel)       Date:  2020-07-07       Impact factor: 4.096

Review 8.  Predicting the CTG Repeat Size from a Single Spirometry Test Performed at Any Time during the Disease Course of Myotonic Dystrophy Type 1.

Authors:  Kazuto Katsuse; Kenichiro Sato; Nobuyuki Tanaka; Idai Uchida; Tatsushi Toda; Takashi Mikata; Yasufumi Motoyoshi
Journal:  Intern Med       Date:  2022-08-01       Impact factor: 1.282

9.  Simultaneous and independent detection of C9ORF72 alleles with low and high number of GGGGCC repeats using an optimised protocol of Southern blot hybridisation.

Authors:  Vladimir L Buchman; Johnathan Cooper-Knock; Natalie Connor-Robson; Adrian Higginbottom; Janine Kirby; Olga D Razinskaya; Natalia Ninkina; Pamela J Shaw
Journal:  Mol Neurodegener       Date:  2013-04-08       Impact factor: 14.195

10.  PCR amplification of a triple-repeat genetic target directly from whole blood in 15 minutes as a proof-of-principle PCR study for direct sample analysis for a clinically relevant target.

Authors:  Christopher M Connelly; Laura R Porter; Joel R TerMaat
Journal:  BMC Med Genet       Date:  2014-12-12       Impact factor: 2.103

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.